BUTITTA CYNTHIA M — SEC Form 4 filings
SEC reporting owner CIK 1222082. 10 Form 4 filings on record with FilingPulse; latest filed 2026-07-01.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-06-18 to 2026-07-01. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 14.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| UroGen Pharma Ltd. (URGN) | Director | 4 | — | — | 7 |
| Olema Pharmaceuticals, Inc. (OLMA) | Director | 3 | — | — | 3 |
| Autolus Therapeutics plc (AUTL) | Director | 1 | — | — | 2 |
| Century Therapeutics, Inc. (IPSC) | Director | 2 | — | — | 2 |
Form 4 filings — BUTITTA CYNTHIA M
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-01 | 4 | Autolus Therapeutics plc (AUTL) | Grant/award (A): 31,667 (derivative) @ $0 · Grant/award (A): 47,500 (derivative) @ $0 | EDGAR |
| 2026-06-24 | 4 | UroGen Pharma Ltd. (URGN) | Grant/award (A): 10,000 (derivative) @ $0 · Grant/award (A): 8,000 (derivative) @ $0 | EDGAR |
| 2026-06-23 | 4 | Olema Pharmaceuticals, Inc. (OLMA) | Grant/award (A): 29,500 (derivative) @ $0 | EDGAR |
| 2025-12-01 | 4 | UroGen Pharma Ltd. (URGN) | Option exercise (M): 2,000 · Option exercise (M): 2,000 (derivative) @ $0 | EDGAR |
| 2025-08-27 | 4 | UroGen Pharma Ltd. (URGN) | Grant/award (A): 10,000 (derivative) @ $0 · Grant/award (A): 8,000 (derivative) @ $0 | EDGAR |
| 2025-06-16 | 4 | Century Therapeutics, Inc. (IPSC) | Grant/award (A): 44,000 (derivative) @ $0 | EDGAR |
| 2025-06-13 | 4 | Olema Pharmaceuticals, Inc. (OLMA) | Grant/award (A): 24,150 (derivative) @ $0 | EDGAR |
| 2024-08-08 | 4 | UroGen Pharma Ltd. (URGN) | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2024-06-21 | 4 | Century Therapeutics, Inc. (IPSC) | Grant/award (A): 44,000 (derivative) @ $0 | EDGAR |
| 2024-06-18 | 4 | Olema Pharmaceuticals, Inc. (OLMA) | Grant/award (A): 23,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1222082 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →